3aHealth is a leading organization specializing in the development of intelligent, citizen-centered eHealth and mHealth solutions, stemming from their extensive experience in research and development.
Their core expertise lies in providing specialized solutions, including bespoke software development, interoperable systems, and patient-centered solutions that enhance the quality of care. Their solutions adhere to EU guidelines and directives for interoperability standards and protocols, ensuring certification by international bodies.
The Motivation Behind Joining VELES
The motivation for joining the project lies in their dedication to research excellence and their commitment to contributing to the advancement of the healthcare industry. The Regional EU Smart Health Data Space offers a strategic opportunity to collaborate with like-minded organizations and stakeholders, driving growth, competitiveness, and job creation within the healthcare value chain.
They expect the project’s successful implementation to bring about significant improvements to the current healthcare situation. The creation of a European Health Data Space, together with cutting-edge technologies, will enable personalized medicine, informed decisions, and improved disease prediction. By aligning endeavors in a coordinated approach, the project will pave the way for an Excellent South-East Europe Smart Health Innovation Ecosystem enabled by a Regional Smart Health Data Space.
Responsibilities & Contribution
By participating in this project, they can actively contribute to the development of innovative healthcare solutions and services, promoting better exchange and cross-border access to health data.
3aHealth will actively support the Multi-ecosystem demonstration and validation of an R&I pilot use case based on the 3Ds Framework and participate in dissemination activities via industry communication channels.
Also, they will provide valuable insights and technical know-how, aiding the design and implementation of the Regional Smart Health Data Space.